Senior insider sale
EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$799.8K
1.54K shares
What this filing means
MCKECHNIE DUNCAN plans to sell 1.54K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $799.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2026ACC: 0001959173-26-005057
Officer· EVP, Chief Commercial Officer
Since Mar 2026
1.54K
Shares to sell
$799.8K
Approx. market value
1.54K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
2/24/2026
929.00Restricted Stock Vesting
Compensation
2/17/2026
612.00Total acquired1.54K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2026 | Restricted Stock Vesting Compensation | 929.00 | — |
2/17/2026 | Restricted Stock Vesting Compensation | 612.00 | — |
| Total | 1.54K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.54K
Market value
$799.8K
7/2/2026
Total
Units
1.54K
Value
$799.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/2/2026 | 1.54K | $799.8K | NASDAQ | Planned |
| Total | 1.54K | $799.8K | ||